These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Ampicillin-sulbactam and ticarcillin-clavulanic acid: a comparison of their in vitro activity and review of their clinical efficacy. Itokazu GS, Danziger LH. Pharmacotherapy; 1991; 11(5):382-414. PubMed ID: 1745624 [Abstract] [Full Text] [Related]
5. [Comparative bacteriostatic activity of ticarcillin, alone and combined with clavulanic acid, 5 cephalosporins and metronidazole against 100 strains of Bacteroides fragilis]. de Barbeyrac B, Quentin C, Bebear C. Pathol Biol (Paris); 1984 May; 32(5):433-5. PubMed ID: 6739151 [Abstract] [Full Text] [Related]
6. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units. Gill CJ, Ponticas S, Shungu DL, Guerriero S. Clin Ther; 1991 May; 13(1):25-37. PubMed ID: 2029725 [Abstract] [Full Text] [Related]
9. Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents. Downes J, Andrew JH. Pathology; 1988 Jul; 20(3):260-3. PubMed ID: 3205597 [Abstract] [Full Text] [Related]
10. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres. Jacobs MR, Spangler SK, Appelbaum PC. J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827 [Abstract] [Full Text] [Related]
11. [In vitro activity of the combination ticarcillin-clavulanic acid on bacterial isolates in surgery]. Branger C, Kitzis M, Le Mée J. Pathol Biol (Paris); 1986 Apr; 34(4):245-8. PubMed ID: 3528998 [Abstract] [Full Text] [Related]
16. In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors. Barry AL, Jones RN, Packer RR. J Antimicrob Chemother; 1986 Jan; 17(1):125-7. PubMed ID: 3005222 [No Abstract] [Full Text] [Related]
17. Comparison of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa. Klepser ME, Marangos MN, Zhu Z, Nicolau DP, Quintiliani R, Nightingale CH. Antimicrob Agents Chemother; 1997 Feb; 41(2):435-9. PubMed ID: 9021203 [Abstract] [Full Text] [Related]
18. A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis. Martin MA, Liebana J, Castillo AM, Gutierrez J, Piédrola G. Microbios; 1991 Feb; 67(272-273):195-202. PubMed ID: 1779879 [Abstract] [Full Text] [Related]
20. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains. Paniagua GL, Monroy E, García O, Vaca S. Rev Latinoam Microbiol; 1998 Feb; 40(3-4):128-34. PubMed ID: 10932741 [Abstract] [Full Text] [Related] Page: [Next] [New Search]